In this study, we investigated the effect of neural cues on patient-derived CRC cell lines selected based on genomic status, e.g., microsatellite instability (MSI) and <i>KRAS</i> and <i>BRAF</i> mutations. This evidence concerns the gene BRAF and colorectal carcinoma.